STOW, Ohio (November 1, 2019) – With healthcare spending projected to rise more than 5 percent each year and three-quarters of that spending tied to chronic disease, the need to better manage medical costs has never been greater. To provide self-insured employers, third party administrators, health plans and others with data that drive smarter, more cost-effective decisions, ProServe Health Informatics is pleased to be part of the Vālenz ecosystem.

Through Planwatch, its flagship product, ProServe Health adds deep, integrated financial analytics to fuel Vālenz Claim, a core component of the Valenz ecosystem. By aggregating and mining in-network and out-of-network medical claim data, Planwatch provides intuitive and detailed financial reporting, as well as plan modeling to help direct and systemically lower healthcare spend.

Including Planwatch in the Valenz ecosystem enables more proactive decision-making and a greater opportunity to disrupt the cost curve. “We are leveraging interoperability with partners like ProServe Health to provide actionable business intelligence that helps clients reduce plan costs, not just in the short term but on a more sustained basis,” said Rob Gelb, Chief Revenue Officer at Valenz. “For robust visibility into in-network and out-of-network medical claims savings, Planwatch supports our promise to engage early and often for smarter, better, faster healthcare.”

Georgeann Seuffert, Vice President of Sales at Planwatch, agrees. “We are pleased to take our existing relationship with Valenz to the next level because we share a common goal to provide solutions that substantially influence better health outcomes and reduce total cost of care,” she said. “It is very refreshing to partner with an organization that wants to invest back into their clients. The Valenz commitment to Planwatch as a value-added service speaks volumes about their dedication to healthcare delivery and savings.”

About ProServe Health Informatics

Planwatch is a product of ProServe Health Informatics. It was developed in 2005 by company co-founders who recognized both the need and the solution for an economical, user-friendly, high level data analysis, web-based reporting, benchmarking, disclosure and plan modeling tool for the Payor community. Planwatch examines historical, current, and future health plan dimensions, integrates, combines and compares pharmacy and medical costs, identifies cost drivers and performance metrics, and provides tested solutions to minimize plan expenditures. Query and produce ad-hoc reports by cost, coverage areas, procedure codes, POS, geographical locations, network performance, prescriptions, and over 150 query fields by employer, participant or payor block of business. For more information about Planwatch, visit their website: www.plan-watch.com or contact Georgeann Seuffert, Vice President of Sales at (888) 275-2242 or gseuffert@proservehealth.com.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners. For more information about Valenz, visit www.valenzhealth.com or call (866) 762-4455.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm, currently with approximately $1.8 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at (203) 971-3300 or www.gppfunds.com.